History
  • No items yet
midpage
United States v. Arman Abovyan
988 F.3d 1288
11th Cir.
2021
Read the full case

Background

  • Kenneth Chatman ran two outpatient substance‑abuse facilities that funneled patients, testing, and insurance billing to specific labs in exchange for kickbacks; labs and other personnel testified about the scheme.
  • Dr. Arman Abovyan served as the Facilities’ medical director (part‑time), signed standing orders authorizing broad, frequent, and expensive lab testing (2–3×/week), and pre‑signed requisition and prescription forms.
  • Abovyan provided nurses with signed prescription pads and his EMR login, rarely examined patients or reviewed/discussed test results, and prescribed buprenorphine (Suboxone) without the required X‑waiver, often listing pain/withdrawal as a pretextual diagnosis.
  • Many specimens were sent for large panel confirmatory testing (costing $1,000–$6,000 each); insurers were billed millions and reimbursements exceeded $1 million.
  • Abovyan was indicted on a healthcare‑fraud conspiracy (Count 1), a drug conspiracy (Count 2), seven substantive unlawful dispensing counts (Counts 3–9), and one possession count; a jury convicted him on Counts 1–9, and he was sentenced to 120 months concurrent plus 15 months consecutive and ordered restitution.

Issues

Issue Plaintiff's Argument (Gov't) Defendant's Argument (Abovyan) Held
Sufficiency — healthcare‑fraud conspiracy (Count 1) Circumstantial proof showed Abovyan knowingly joined and advanced scheme: standing orders, pre‑signed forms, billing participation, payments, and delegation that furthered fraud. At worst negligent or sloppy medical practice; no direct proof he agreed to or knew of fraud; no documents/emails proving agreement. Affirmed — circumstantial evidence sufficient to prove knowledge and willful participation in conspiracy.
Sufficiency — controlled substances (Counts 2–9) Prescriptions were not for legitimate medical purposes / outside usual practice: no assessments, pre‑signed pads, no follow‑up on failed tests, no X‑waiver, prescriptions served scheme. Prescriptions were for legitimate addiction treatment; lack of X‑number alone does not establish §841 violation. Affirmed — evidence supported that prescriptions were not legitimately issued or in usual course of practice.
Jury instructions — omission of substantive healthcare‑fraud elements and X‑number treatment Instructions adequately described conspiracy and referenced the indictment; overall charge and indictment cured omission; court did not create strict liability from X‑number. District court plainly erred by not instructing the elements of healthcare fraud and by implying strict liability for X‑number. No reversible error — instructions viewed as whole were correct; any omission did not affect substantial rights; no strict §841 liability based solely on X‑number.
Sentencing — loss amount, disparity, and statutory maximum for Count 2 Intended loss (≥ $11.3M billed during Abovyan’s tenure) was properly applied; co‑conspirators who pled are not similarly situated; Schedule III buprenorphine bounds Count 2 max. Use actual (≈ $1M) not intended loss to avoid disparity; co‑defendant sentences based on actual loss; Count 2 ambigious as to drug schedule should get lowest maximum (Schedule IV). Affirmed — guidelines permit intended loss; no unwarranted disparity because others pled; Count 2 max limited by substantive buprenorphine convictions (Schedule III).

Key Cases Cited

  • United States v. Ruan, 966 F.3d 1101 (11th Cir. 2020) (standards for §841 medical‑purpose/usual‑course analysis in physician prescribing cases)
  • United States v. Joseph, 709 F.3d 1082 (11th Cir. 2013) (prescribing without exam or with pre‑signed prescriptions supports §841 conviction)
  • United States v. Merrill, 513 F.3d 1293 (11th Cir. 2008) (focus on whether prescribing conforms to accepted medical standards)
  • United States v. Willner, 795 F.3d 1297 (11th Cir. 2015) (reversing where circumstantial evidence of conspiracy was weak)
  • United States v. Ganji, 880 F.3d 760 (5th Cir. 2018) (reversing medical‑director conspiracy where record rebutted government’s theory)
  • Neder v. United States, 527 U.S. 1 (1999) (omission of an element in jury instruction is not always reversible error)
  • United States v. Gonzalez, 834 F.3d 1206 (11th Cir. 2016) (instructional omissions cured by indictment and charge viewed as whole)
  • United States v. Melgen, 967 F.3d 1250 (11th Cir. 2020) (district court loss findings entitled to deference; reasonable estimate standard)
  • United States v. Candelario, 240 F.3d 1300 (11th Cir. 2001) (substantive convictions can supply drug‑type finding for conspiracy sentencing)
Read the full case

Case Details

Case Name: United States v. Arman Abovyan
Court Name: Court of Appeals for the Eleventh Circuit
Date Published: Feb 22, 2021
Citation: 988 F.3d 1288
Docket Number: 19-10676
Court Abbreviation: 11th Cir.